Advertisement

Early Combination of Lipid-Lowering Therapy Beneficial After Myocardial Infarction

0

In a recent study, one-year MACE incidences were 1.79, 2.58, and 4.03 per 100 patient-years for early, late, and no ezetimibe added to statins

Efanesoctocog Alfa Not Cost-Effective for Prophylaxis in Hemophilia A

0

Efanesoctocog alfa needs to be priced at <53 and <59 percent of current price for conventional and distributional cost-effectiveness

United States Seeing Uptick in Whooping Cough Cases

0

Number of cases this year has reached 8,485, twice as many as this time last year

Common Medications Tied to Older Age at Onset of Parkinson Disease

0

Almost 10-year delay seen for patients who were started on adrenergic blockers before onset of PD symptoms

Novavax COVID Vaccine Moves Closer to Full FDA Approval

0
By I. Edwards HealthDay Reporter FRIDAY, April 25, 2025 (HealthDay News) — Novavax’s COVID-19 vaccine could soon receive full approval from the U.S. Food and...

HHS Announces Plans to Pay Moderna $176 Million for mRNA Flu Vaccine

0

Government hopes to be prepared for possible bird flu pandemic or outbreak of other flu variations

Brensocatib Leads to Lower Rate of Pulmonary Exacerbations in Bronchiectasis

0

Annualized rate of pulmonary exacerbations lower in 10-mg and 25-mg brensocatib groups versus placebo

Single-Dose Baloxavir Treatment Can Reduce Influenza Transmission

0

Transmission of laboratory-confirmed influenza significantly lower with baloxavir versus placebo by day 5

School-Based Asthma Therapy Boosts Asthma Control, Cuts Acute Health Care Use

0

Program also helps close health disparities gap for Black and Latino children at high risk for poor asthma outcomes

U.S. Faces Largest Measles Outbreak Since 2000

0
By I. Edwards HealthDay Reporter THURSDAY, April 24, 2025 (HealthDay News) — The United States is now experiencing its largest measles outbreak since the disease...